BlackRock Amends Abbott Labs Stake, Signals Continued Confidence
Ticker: ABT · Form: SC 13G/A · Filed: Jan 26, 2024 · CIK: 1800
| Field | Detail |
|---|---|
| Company | Abbott Laboratories (ABT) |
| Form Type | SC 13G/A |
| Filed Date | Jan 26, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**BlackRock still holds Abbott Labs, showing big institutional confidence.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 26, 2024, indicating its ownership of Abbott Laboratories' Common Stock as of December 31, 2023. This is Amendment No. 12 to their previous filings, showing BlackRock continues to be a significant institutional holder of Abbott Laboratories shares. This matters to investors because BlackRock is one of the world's largest asset managers, and their continued substantial holding signals confidence in Abbott Laboratories' long-term prospects, potentially influencing other institutional and retail investors.
Why It Matters
BlackRock's ongoing significant ownership in Abbott Laboratories suggests institutional confidence, which can positively influence market perception and stability for current and prospective shareholders.
Risk Assessment
Risk Level: low — This filing is routine for large institutional investors and does not indicate any immediate negative or positive risk for the stock.
Analyst Insight
Investors should note BlackRock's continued presence as a major shareholder, which can be a positive signal of institutional confidence, but this filing alone doesn't warrant immediate buying or selling action.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person filing the SC 13G/A
- Abbott Laboratories (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 26, 2024 (date) — the filing date of the SC 13G/A
- 002824100 (other) — the CUSIP number for Abbott Laboratories Common Stock
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing under the Securities Exchange Act of 1934, specifically Amendment No. 12.
Who is the reporting person in this filing?
The reporting person is BlackRock, Inc., identified by CIK 0001364742.
What company's securities are being reported on?
The securities being reported on are the Common Stock of Abbott Laboratories, identified by CIK 0000001800.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023.
Under which rule is this Schedule 13G filed?
This Schedule 13G is filed under Rule 13d-1(b), as indicated by the 'X' in the appropriate box.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 26, 2024 regarding ABBOTT LABORATORIES (ABT).